Table 5.
Base-case cost-effectiveness analysis of MFNS versus BDNS for pediatric allergic rhinitis treatment
Category | Strategy | Cost (US$) | Incremental cost (US$) | Effectiveness (TIX score) | Incremental effectiveness (TIX score) | Cost/effectiveness |
---|---|---|---|---|---|---|
MFNS | 229.78 | – | 0.9724 | – | 236.31 | |
Absolutely dominated | BDNS | 289.74 | 59.96 | 0.8712 | −0.1012 | 332.58 |
BDNS beclomethasone dipropionate nasal spray, MFNS mometasone furoate nasal spray, TIX therapeutic index